Skip to content

A study on the maintenance treatment of depression patients with accelerated sequential TBS combined with transcranial direct current stimulation and exploration of its mechanism

A study on the maintenance treatment of depression patients with accelerated sequential TBS combined with transcranial direct current stimulation and exploration of its mechanism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107361
Enrollment
Unknown
Registered
2025-08-10
Start date
2025-08-10
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive symptoms

Interventions

Sponsors

Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18~65 years old; 2. Patients experiencing a non-psychotic major depressive episode as defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) with moderate to severe levels of treatment resistance as measured by the Maudsley staging method (MSM). 3. Those who have undergone at least two antidepressants with different mechanisms of action, and have been treated with sufficient amounts and full courses of treatment with poor efficacy or no response. 4. The total score of HAMD-24 items > 20 points; 5. Patients who were able to complete the first 5 days of accelerated iTBS therapy with an effective rate of 50%; 6. right-handed; 7. The patient's physical examination, medical history, vital signs, hematuria and stool routine, liver and kidney function, electrolytes, electrocardiogram, electroencephalogram and other indicators were normal; 8. After fully understanding the safety of transcranial magnetic stimulation (TMS), willing to actively cooperate with the treatment, and signed informed consent by the person and his family.

Exclusion criteria

Exclusion criteria: 1. Age 65 years old; 2. Those with a history of severe physical illness and other psychoactive substances and depression caused by non-dependent substances; 3. The patient has metal or electronic devices built into the body, such as intracranial metal foreign bodies, cochlear implants, pacemakers, stents and other metal foreign bodies; 4. Have a risk of seizures, have previous craniocerebral disease, head trauma, alcoholism, electroencephalogram abnormalities, MRI evidence of brain structural abnormalities, or have a family history of epilepsy; 5. Those who have psychotic symptoms and need to take antipsychotic drugs; 6. ECT therapy within 2 months prior to enrollment; 7. Refusal to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Clinical scale;

Secondary

MeasureTime frame
Electroencephalogram;fNIRS;3.0T magnetic resonance imaging (MRI);Electromyography;

Countries

China

Contacts

Public ContactLi Xingxing

Affiliated Kangning Hospital of Ningbo University

290534201@qq.com+86 138 5747 6641

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026